Literature DB >> 23690479

Superantigen-induced steroid resistance depends on activation of phospholipase Cβ2.

Auke P Verhaar1, Manon E Wildenberg, Marjolijn Duijvestein, Anne Christine W Vos, Maikel P Peppelenbosch, Mark Löwenberg, Daniel W Hommes, Gijs R van den Brink.   

Abstract

The glucocorticoid receptor is present in a TCR-associated complex, which includes the Src family tyrosine kinase Lck. Glucocorticoids rapidly dissociate this complex, resulting in the inhibition of canonical Lck-phospholipase C (PLC)γ-dependent TCR signaling. The relative importance of this nongenomic role for the glucocorticoid receptor compared with its direct transcriptional effects is not known. Superantigens induce a state of steroid resistance in activated T cells. It was reported that, in addition to canonical Lck-PLCγ signaling, superantigens can activate a noncanonical G protein-PLCβ-dependent signaling pathway. In this study, we show that staphylococcal enterotoxin B activates a Gαq and PLCβ2-dependent pathway in human T cells. We find that this pathway bypasses the need for canonical Lck-PLCγ signaling in T cell activation and renders superantigen-stimulated T cells insensitive to glucocorticoids in vitro. We show that the PLCβ inhibitor U-73122 sensitizes staphylococcal enterotoxin B-treated mice to dexamethasone in vivo. In conclusion, we find that effects of glucocorticoids on TCR-induced T cell proliferation are mainly nongenomic and can be bypassed by the activation of an Lck-independent signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690479     DOI: 10.4049/jimmunol.1202898

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

Review 1.  Phospholipase C-β in immune cells.

Authors:  Toshiaki Kawakami; Wenbin Xiao
Journal:  Adv Biol Regul       Date:  2013-08-14

2.  High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation.

Authors:  Hirofumi Kashiwagi; Toshiro Seki; Shino Oshima; Yusuke Ohno; Tomoka Shimizu; Soga Yamada; Nagi Katano; Yumiko Goto; Atsushi Yasuda; Banri Tsuda; Ryoji Ito; Shun-Ichiro Izumi; Hitoshi Ishimoto; Takashi Shiina; Yoshie Kametani
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.